Quantitative dynamic evaluation HBsAg in blood in comparison to viral load level in patients with chronic HBV-monoinfection

Quantitative dynamic evaluation HBsAg in blood in comparison to viral load level in patients with chronic HBV-monoinfection

Aim of investigation. Quantitative analysis of HBsAg contents in the blood in relation to HBV viremia level in patients with various variants of natural course of chronic HBV-infection at dynamic evaluation within 1,5–2 years.Material and methods. Overall 135 patients with chronic HBV-monoinfection...

Full description

Saved in:

Bibliographic Details
Main Authors:	K. R. Dudina, O. O. Znoyko, S. A. Shutko, Ye. A. Klimova, L. Ye. Kuzina, D. M. Braginsky, N. P. Blokhina, N. D. Yushchuk
Format:	Article
Language:	Russian
Published:	Gastro LLC 2011-06-01
Series:	Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:	chronic hepatitis b hbsag concentration hepatitis b virus inactive carriage hbv viremia level
Online Access:	https://www.gastro-j.ru/jour/article/view/1437
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Protracted HBsAg-aemia in a Patient with Acute Hepatitis B
by: K. R. Dudina, et al.
Published: (2018-11-01)

Reevaluating antiviral thresholds in HBV DNA-negative inactive HBsAg carriers: a multicenter histopathological analysis
by: Shan Ren, et al.
Published: (2025-07-01)

Development of Low-Cost In-House Assays for Quantitative Detection of HBsAg, HBeAg, and HBV DNA to Enhance Hepatitis B Virus Diagnostics and Antiviral Screening in Resource-Limited Settings
by: Simmone D’souza, et al.
Published: (2025-03-01)

Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies
by: Lorenzo Piermatteo, et al.
Published: (2023-12-01)

Clinical laboratory characteristic of hospitalized patients with HBsAg negative chronic hepatitis B
by: E. O. Shibaeva, et al.
Published: (2014-09-01)

Using the quantitative determination of HBsAg to predict the course of chronic hepatitis B in women during pregnancy and after childbirth
by: M. A. Belopolskaya, et al.
Published: (2014-09-01)

Adding pegylated interferon-α to nucleos(t)ide analogs improves HBsAg clearance in chronic hepatitis B with low-level viremia
by: Lilin Wang, et al.
Published: (2025-08-01)

HBsAg clearance and seroconversion case in a patient with HBeAg-negative chronic hepatitis B on pegylated interferon α-2a therapy
by: K. V. Zhdanov, et al.
Published: (2014-09-01)

Vaccination Effect on Epidemic Process of Viral Hepatitis B In Republic of Belarus
by: V. S. Vysotskaya, et al.
Published: (2019-03-01)

Correlation between serum quantitative HBsAg and HBV DNA levels in chronic hepatitis B patients
by: Pete Maria, et al.
Published: (2023-01-01)

Prediction of long-term HBsAg seroclearance in patients with HBeAg-negative chronic hepatitis B
by: Hae Lim Lee, et al.
Published: (2025-07-01)

Exploring using HBsAg to predict interferon treatment course to achieve clinical cure in chronic hepatitis B patients: a clinical study
by: Fei Yan, et al.
Published: (2025-01-01)

Discussion on the duration of response following HBsAg clearance in patients with chronic hepatitis B treated with PegIFNα-2b
by: Tao Wang, et al.
Published: (2025-04-01)

Hepatitis B vaccination in Burkina Faso: prevalence of HBsAg carriage and immune response in children in the western region
by: Armel Moumouni Sanou, et al.
Published: (2018-11-01)

Erişkin HBsAg Pozitif Hastalarda Hepatit A Seroprevalansı
by: Alper Tahmaz, et al.
Published: (2020-09-01)

Distribution of Major Histocompatibility Complex Alleles in Cohorts of Patients with Different Levels of Post-Vaccination Antibodies against Hepatitis B
by: N. V. Vlasenko, et al.
Published: (2024-07-01)

High HBsAg clearance rate and viral dynamics in HBeAg-positive, ALT-normal children and adolescents with chronic HBV infection: results from the prospective sprout project
by: Xin Wang, et al.
Published: (2025-12-01)

Immunological and Virological Responses in Patients with Monoinfection and Coinfection with Hepatitis B and C Viruses in the Brazilian Amazon
by: Joseane R. Silva, et al.
Published: (2025-06-01)

Efficacy of extracorporeal immunoadsorption therapy for removal of HBsAg
by: Meng Wang, et al.
Published: (2025-07-01)

Increasing Prevalence of Occult HBV Infection in Adults Vaccinated Against Hepatitis B at Birth
by: Ge Zhong, et al.
Published: (2025-02-01)

Predictors of HBsAg seroclearance in HBeAg-negative chronic hepatitis B patients treated with nucleotide analogs plus polyethylene glycol interferon
by: Yan Peng, et al.
Published: (2025-01-01)

Comparison of HBV-DNA Levels with Biochemical and Microbiological Parameters for Chronic Hepatitis Evaluation, Bursa, Turkey
by: Sanem Karadag Gecgel
Published: (2021-03-01)

Serum hepatitis B virus RNA in low-level viremia of chronic hepatitis B: clinical features and association with virological response
by: Yongbin Wu, et al.
Published: (2025-05-01)

The presence of baseline HBsAb-Specific B cells can predict HBsAg or HBeAg seroconversion of chronic hepatitis B on treatment
by: Shengxia Yin, et al.
Published: (2023-12-01)

HBsAg and anti-HBs coexistence in patients with HBV in acute and chronic phases
by: Zhongshu Pu, et al.
Published: (2025-05-01)

Characterization of Hepatitis B Virus Transcripts in Chronically HBV-Infected Chimpanzees and Patients Treated with ARC-520 siRNA Demonstrates Transcriptional Silencing of cccDNA
by: Christine I. Wooddell, et al.
Published: (2024-12-01)

Hepatitis B and C infection in HIV-infected children and young adults attending HIV treatment centres in Calabar, Nigeria
by: Joanah Ikobah, et al.
Published: (2024-12-01)

Predictive value of HBeAg titer dynamics for HBsAg clearance in pediatric chronic hepatitis B
by: Sukjin Hong, et al.
Published: (2025-04-01)

Decreased risk of nosocomial transmission of hepatitis B and C viruses among hemodialysis patients in Southern Bulgaria
by: Radka T Komitova, et al.
Published: (2025-05-01)

Prevalence of HBsAg among Moroccan HIV-1 infected patients and APOBEC3G variant frequencies in HIV-1/HBV co-infection
by: Imane Belbacha, et al.
Published: (2024-05-01)

Mechanisms underlying delayed loss of HBeAg and HBV DNA following HBsAg seroclearance in PEG-IFNα treated patients of chronic hepatitis B
by: Bei Jiang, et al.
Published: (2025-12-01)

Hepatocellular Carcinoma in Delta Hepatitis Versus HBV Monoinfection: Spot the Differences
by: Razvan Cerban, et al.
Published: (2025-05-01)

Nucleos(t)ide analogs continuation is not associated with a lower risk of HBsAg seroreversion following PEG-IFN-induced HBsAg loss
by: Na Gao, et al.
Published: (2025-03-01)

Prevalence and Transfusion Risks of Occult Hepatitis B Infection Among HBcAb-Positive Blood Donors in a High-Endemic Region
by: Ahmed Subeh Alshrari, et al.
Published: (2025-02-01)

Incidence and determinants of achieving HBsAg <100 IU/mL in HBeAg-negative CHB patients with nucleos(t)ide analogue treatment
by: Jian Wang, et al.
Published: (2025-08-01)

Clinical and laboratory characteristics of occult hepatitis B
by: E. V. Esaulenko, et al.
Published: (2016-04-01)

Maternal and neonatal seroprevalence of Hepatitis B surface antigen (HBsAg) in Tripoli, Libya
by: Hamida El-Magrahe, et al.
Published: (2010-03-01)

Seroepidemiology of hepatitis B virus infection among Chinese schizophrenia patients
by: Huijuan Zhu, et al.
Published: (2015-05-01)

Clinical usefulness of an ultra-high-sensitivity hepatitis B surface antigen assay to determine the cessation of treatment for HBV reactivation
by: Takanori Suzuki, et al.
Published: (2025-01-01)

Analysis of HBV infection characteristics and OBI prevalence in pregnant women: a focus on HBcAb + alone or in combination with HBeAb + subgroups in Northwest China
by: Yun Xie, et al.
Published: (2025-08-01)